Advertisement

Rheumatology International

, Volume 38, Issue 7, pp 1163–1168 | Cite as

Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know

  • Mohanned Mustafa
  • Easwaradhas Gladston Chelliah
  • Michael HughesEmail author
Expert Opinion

Abstract

Patients with systemic rheumatic diseases (SRDs) may require admission to the intensive care unit (ICU) throughout the course of their disease. Therefore, the rheumatologist needs an understanding of the factors which may influence the course of patients with SRDs who are admitted to ICU. These include the causes for admission, patient characteristics including comorbidities and drug therapies, outcome (in-ICU mortality and causes of death), and prognostic factors. Infections and exacerbation/complications of SRDs are the most common (and potentially reversible) reasons for both admission and death on ICU. Mortality in patients with SRDs admitted to ICU has been reported to be either no different or higher than ‘general’ ICU patients. Reported prognostic factors included patient and disease characteristics, as well as ICU factors, including scoring systems. Rheumatologists need to be aware of the factors surrounding admission of patients with SRDs to ICU, including the need for strong links with critical care medicine.

Keywords

Rheumatology Systemic rheumatic diseases Intensive care unit Prognosis Outcomes 

Notes

Compliance with ethical standards

Conflict of interest

No authors have any potential conflicts of interest.

References

  1. 1.
    Godeau B, Boudjadja A, Dhainaut JF, Schlemmer B, Chastang C, Brunet F et al (1992) Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 51:627–631CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Godeau B, Mortier E, Roy PM, Chevret S, Bouachour G, Schlemmer B et al (1997) Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 24:1317–1323PubMedGoogle Scholar
  3. 3.
    Janssen NM, Karnad DR, Guntupalli KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 18:729–748CrossRefPubMedGoogle Scholar
  4. 4.
    Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F et al (2005) Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 14:315–320CrossRefPubMedGoogle Scholar
  5. 5.
    Antón JM, Castro P, Espinosa G, Marcos M, Gandía M, Merchán R et al (2012) Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study. Clin Exp Rheumatol 30:338–344PubMedGoogle Scholar
  6. 6.
    Faguer S, Ciroldi M, Mariotte E, Galicier L, Rybojad M, Canet E et al (2013) Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med 24:e40–e44CrossRefPubMedGoogle Scholar
  7. 7.
    Bernal-Macías S, Reyes-Beltrán B, Molano-González N, Augusto Vega D, Bichernall C, Díaz LA et al (2015) Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med 2:e000122CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Heijnen T, Wilmer A, Blockmans D, Henckaerts L (2016) Outcome of patients with systemic diseases admitted to the medical intensive care unit of a tertiary referral hospital: a single-centre retrospective study. Scand J Rheumatol 45:146–150CrossRefPubMedGoogle Scholar
  9. 9.
    Thong BY, Tai DY, Goh SK, Johan A (2001) An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singap 30:254–259PubMedGoogle Scholar
  10. 10.
    Moreels M, Mélot C, Leeman M (2005) Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 31:591–593CrossRefPubMedGoogle Scholar
  11. 11.
    Cavallasca JA, del Rosario Maliandi M, Sarquis S, Nishishinya MB, Schvartz A, Capdevila A et al (2010) Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol 16:400–402CrossRefPubMedGoogle Scholar
  12. 12.
    Brünnler T, Susewind M, Hoffmann U, Rockmann F, Ehrenstein B, Fleck M (2015) Outcomes and prognostic factors in patients with rheumatologic diseases admitted to the ICU. Intern Med 54:1981–1987CrossRefPubMedGoogle Scholar
  13. 13.
    Pène F, Hissem T, Bérezné A, Allanore Y, Geri G, Charpentier J et al (2015) Outcome of patients with systemic sclerosis in the intensive care unit. J Rheumatol 42:1406–1412CrossRefPubMedGoogle Scholar
  14. 14.
    Shalev T, Haviv Y, Segal E, Ehrenfeld M, Pauzner R, Levy Y et al (2006) Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases. Clin Exp Rheumatol 24:380–386PubMedGoogle Scholar
  15. 15.
    Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M et al (2007) Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol 26:1851–1855CrossRefPubMedGoogle Scholar
  16. 16.
    Peng J-M, Du B, Wang Q, Weng L, Hu X-Y, Wu C-Y et al (2016) Dermatomyositis and polymyositis in the intensive care unit: a single-center retrospective cohort study of 102 patients. PLoS ONE 11:e0154441CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hsu C-L, Chen K-Y, Yeh P-S, Hsu Y-L, Chang H-T, Shau W-Y et al (2005) Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care 9:R177CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Ñamendys-Silva S, Baltazar-Torres J, Rivero-Sigarroa E, Fonseca-Lazcano J, Montiel-López L, Domínguez-Cherit G (2009) Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus 18:1252–1258CrossRefPubMedGoogle Scholar
  19. 19.
    Fatemi A, Shamsaee S, Raeisi A, Sayedbonakdar Z, Smiley A (2017) Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit. Clin Rheumatol 36:2471–2477CrossRefPubMedGoogle Scholar
  20. 20.
    Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y et al (2003) Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology 42:1183–1188CrossRefPubMedGoogle Scholar
  21. 21.
    Khan SA, Subla MR, Behl D, Specks U, Afessa B (2007) Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest 131:972–976CrossRefPubMedGoogle Scholar
  22. 22.
    Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V (2008) Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit. Ren Fail 30:890–895CrossRefPubMedGoogle Scholar
  23. 23.
    Befort P, Corne P, Filleron T, Jung B, Bengler C, Jonquet O et al (2013) Prognosis and ICU outcome of systemic vasculitis. BMC Anesthesiol 13:27CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Monti S, Montecucco C, Pieropan S, Mojoli F, Braschi A, Caporali R (2015) Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series. Clin Exp Rheumatol 33:S-126-31PubMedGoogle Scholar
  25. 25.
    Kimmoun A, Baux E, Das V, Terzi N, Talec P, Asfar P et al (2015) Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Crit Care 20:27CrossRefGoogle Scholar
  26. 26.
    Dumas G, Géri G, Montlahuc C, Chemam S, Dangers L, Pichereau C et al (2015) Outcomes in critically ill patients with systemic rheumatic disease. Chest 148:927–935CrossRefPubMedGoogle Scholar
  27. 27.
    Peschken CA, Hitchon CA, Garland A, Bernstein CN, Chen H, Fransoo R et al (2016) A population-based study of intensive care unit admissions in rheumatoid arthritis. J Rheumatol 43:26–33CrossRefPubMedGoogle Scholar
  28. 28.
    Ozbalkan Z, Topeli A, Kiraz S, Ozturk MA, Ertenli I, Calguneri M (2004) The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: a matched cohort study. Clin Exp Rheumatol 22:223–226PubMedGoogle Scholar
  29. 29.
    Haviv Y, Shovman O, Bragazzi NL, Sharif K, Yavne Y, Shoenfeld Y et al (2017) Patients with vasculitides admitted to the intensive care unit: implications from a single-center retrospective study. J Intensive Care Med.  https://doi.org/10.1177/0885066617717223 PubMedCrossRefGoogle Scholar
  30. 30.
    Demiselle J, Auchabie J, Beloncle F, Gatault P, Grangé S, Du Cheyron D et al (2017) Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study. Ann Intensive Care 7:39CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Beil M, Sviri S, de la Guardia V, Stav I, Ben-Chetrit E, van Heerden PV (2017) Prognosis of patients with rheumatic diseases admitted to intensive care. Anaesth Intensive Care 45:67–72PubMedGoogle Scholar
  32. 32.
    Faverio P, Pesci A, Esquinas AM (2016) Systemic sclerosis and outcome in intensive care unit: do not close the door, open the right protocol. J Rheumatol 43:676–677CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Rheumatology, Wrightington HospitalWrightington, Wigan and Leigh NHS Foundation TrustWiganUK
  2. 2.Department of RheumatologySheffield University Hospitals NHS Foundation TrustSheffieldUK

Personalised recommendations